SCHEMBL22745294

SCHEMBL22745294

Cc1cccc(/C=C/[C@H]2CCCN2C(=O)OC(C)(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.49
MAPT P10636 1/20 0.49
LMNA P02545 2/20 0.48
GPR119 Q8TDV5 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.43
GRM5 P41594 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
UCHL1 P09936 2/20 0.42
NPC1 O15118 1/20 0.40
POLB P06746 2/20 0.40
USP30 Q70CQ3 1/20 0.39
EPHX2 P34913 1/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19897164 0.88 RIPK1 (0.48) NPSR1MAPTLMNAGPR119L3MBTL1
SCHEMBL2545923 0.88 USP30 (0.47) NPSR1MAPTLMNAL3MBTL1GRM5
SCHEMBL19897161 0.88 RIPK1 (0.48) NPSR1MAPTLMNAGPR119L3MBTL1
SCHEMBL31306998 0.88 RIPK1 (0.48) NPSR1MAPTLMNAGPR119L3MBTL1
SCHEMBL19897159 0.88 RIPK1 (0.48) NPSR1MAPTLMNAGPR119L3MBTL1
SCHEMBL6012032 0.87 MEN1 (0.53) NPSR1LMNAGPR119L3MBTL1MEN1
SCHEMBL3052925 0.87 MEN1 (0.53) NPSR1LMNAGPR119L3MBTL1MEN1
SCHEMBL3052928 0.87 MEN1 (0.53) NPSR1LMNAGPR119L3MBTL1MEN1
SCHEMBL19935193 0.85 NPC1 (0.42) NPSR1MAPTLMNAL3MBTL1MEN1
SCHEMBL7487281 0.81 GPR119 (0.47) NPSR1MAPTLMNAGPR119L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504214-B1 FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2020-12-02 EP disclosed